Evaluating the Pre-Positioning Frame for Robotic Acoustic Neuroma Removal Surgery (PPF)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03057678 |
Recruitment Status :
Not yet recruiting
First Posted : February 20, 2017
Last Update Posted : January 25, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Acoustic Neuroma | Other: Testing of Pre-Positioning Frame | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 10 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Masking Description: | Open Label |
Primary Purpose: | Basic Science |
Official Title: | Evaluating the Pre-Positioning Frame for Robotic Acoustic Neuroma Removal Surgery |
Estimated Study Start Date : | December 2021 |
Estimated Primary Completion Date : | December 2021 |
Estimated Study Completion Date : | December 2022 |

Arm | Intervention/treatment |
---|---|
Experimental: Testing of Pre-Positioning Frame
Placement of bone screws, CT scanning, Surgical planning, Robot motion planning
|
Other: Testing of Pre-Positioning Frame
Placement of bone screws, CT scanning, Surgical planning, Robot motion planning |
- Time in minutes required to attach the PPF. [ Time Frame: From PPF anchored to temporal bone until bone screws are loosened and PPF removed, estimated 15-30 minutes. ]
- Percentage of planned mastoidectomy reachable by robot [ Time Frame: During the use of the PPF, estimated 15-30 minutes. ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 21 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients 21-80 years old undergoing TANR who consent to participation.
- Preop Head CT scan as part of routine care.
- Skull thickness a minimum of 3.75mm in planned attachment areas.
Exclusion Criteria:
- Pregnant women. As per standard of care in preparation for surgery, all females of childbearing age will undergo a pregnancy test during the medical evaluation for surgery.
- Patients with severe comorbidities, such as chronic otitis media, history of stroke, brain trauma, or hydrocephalus.
- Patients with a history of allergic reactions to lidocaine.
- Patients with severe anatomical abnormality of the temporal bone.
- Patients with history of allergic reaction to titanium, because the bone screws used in this study are made of a titanium alloy.
- Patients who are at unacceptable risk for general anesthesia.
- Patients who are at unacceptable risk for the intraoperative CT scan(s).
- Patients who are unable to give informed consent.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03057678
Contact: Robert F. Labadie, MD, PhD | 615-936-2493 | robert.labadie@vanderbilt.edu | |
Contact: Kate Von Wahlde, MJ, CCRP | 615-322-0333 | kate.vonwahlde@vumc.org |
United States, Tennessee | |
Vanderbilt University Medical Center | |
Nashville, Tennessee, United States, 37232 |
Principal Investigator: | Robert F. Labadie, MD, PhD | Vanderbilt University Medical Center | |
Study Director: | Robert J. Webster, PhD | Vanderbilt University |
Responsible Party: | Robert F. Labadie, Vice Chair, Chief Research Officer, Professor of Otolaryngology-Head and Neck Surgery, Professor of Biomedical Engineering, Vanderbilt University Medical Center |
ClinicalTrials.gov Identifier: | NCT03057678 |
Other Study ID Numbers: |
151347 R01DC012593 ( U.S. NIH Grant/Contract ) |
First Posted: | February 20, 2017 Key Record Dates |
Last Update Posted: | January 25, 2021 |
Last Verified: | January 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Neuroma Neuroma, Acoustic Nerve Sheath Neoplasms Neoplasms, Nerve Tissue Neoplasms by Histologic Type Neoplasms Neurilemmoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms, Germ Cell and Embryonal Cranial Nerve Neoplasms |
Nervous System Neoplasms Neoplasms by Site Peripheral Nervous System Neoplasms Vestibulocochlear Nerve Diseases Retrocochlear Diseases Ear Diseases Otorhinolaryngologic Diseases Otorhinolaryngologic Neoplasms Cranial Nerve Diseases Nervous System Diseases |